Eisai
4523.T
#1988
Rank
S$10.72 B
Marketcap
$38.06
Share price
0.47%
Change (1 day)
-31.85%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): S$0.59 Billion

According to Eisai's latest financial reports the company's current earnings are S$5.06 Billion. In 2023 the company made an earning of S$0.69 Billion, an increase over its 2022 earnings that were of -S$30.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.59 B-15.27%
2023 S$0.69 B-2392.87%
2022 -S$30.43 Million-103.6%
2021 S$0.84 B-39.52%
2020 S$1.39 B7.3%
2019 S$1.30 B17.23%
2018 S$1.11 B86.06%
2017 S$0.59 B-23.64%
2016 S$0.78 B27.28%
2015 S$0.61 B22.08%
2014 S$0.50 B-46.11%
2013 S$0.93 B-21.67%
2012 S$1.19 B-20.72%
2011 S$1.50 B-8.44%
2010 S$1.64 B18.85%
2009 S$1.38 B